出版物 打印 Donegan D, Bornhorst J, Van Gompel J, Atkinson J, Theobald JP, Meyer FF, Link MJ, Peris-Celda M, Spears G, Erickson D. Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency. J Neurosurg. 2024 May 1; 140 (5):1276-1284 Epub 2023 Nov 10 View PubMed Cohen-Cohen S, Rindler R, Botello Hernandez E, Donegan D, Erickson D, Meyer FB, Atkinson JL, Van Gompel JJ. A Novel Preoperative Score to Predict Long-Term Biochemical Remission in Patients with Growth-Hormone Secreting Pituitary Adenomas. World Neurosurg. 2024 Feb; 182:e882-e890 Epub 2023 Dec 18 View PubMed Dogra P, Bedatsova L, Van Gompel JJ, Giannini C, Donegan DM, Erickson D. Long-term outcomes in patients with adult-onset craniopharyngioma. Endocrine. 2022 Oct; 78 (1):123-134 Epub 2022 July 23 View PubMed Donegan D, Erickson D. Revisiting Pituitary Apoplexy. J Endocr Soc. 2022 Sep 1; 6 (9):bvac113 Epub 2022 July 26 View PubMed Donegan D, Algeciras-Schimnich A, Ashrafzadeh-Kian S, Erickson D. Insulin-Like Growth Factor 1 in the Early Postoperative Assessment of Acromegaly. Am J Clin Pathol. 2022 Apr 1; 157 (4):595-601 View PubMed Donegan D, Saeed Z, Delivanis DA, Murad MH, Honegger J, Amereller F, Oguz SH, Erickson D, Bancos I. Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2022 Mar 24; 107 (4):1170-1190 View PubMed Donegan D, Gowan T, Gruber R, Cottingham A, Flanagan M, Erickson D, Imperiale TF. The Need for Patient-centered Education Among Patients Newly Diagnosed With a Pituitary Tumor. J Endocr Soc. 2021 Jun 1; 5 (6):bvab061 Epub 2021 Apr 07 View PubMed Donegan D, Bancos I. Editorial. Curr Opin Endocrinol Diabetes Obes. 2021 Jun 1; 28 (3):263-264 View PubMed Al Sabie F, Tariq Z, Erickson D, Donegan D. Association Between Prolactinoma and Body Mass Index. Endocr Pract. 2021 Apr; 27 (4):312-317 Epub 2020 Dec 13 View PubMed Swanson AA, Erickson D, Donegan DM, Jenkins SM, Van Gompel JJ, Atkinson JLD, Erickson BJ, Giannini C. Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary. 2021 Apr; 24 (2):192-206 Epub 2020 Oct 19 View PubMed Erickson D, Donegan D. Diagnosis and Management of Neuroendocrine Disorders of Survivors of Brain Tumors. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:1-9 View PubMed Chang AY, Mirfakhraee S, King EE, Mercado JU, Donegan DM, Yuen KC. Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases. Clin Med Insights Endocrinol Diabetes. 2021; 14:1179551421994102 Epub 2021 Mar 04 View PubMed Li T, Donegan D, Hooten WM, Bancos I. Clinical Presentation and Outcomes of Opioid-Induced Adrenal Insufficiency. Endocr Pract. 2020 Nov; 26 (11):1291-1297 View PubMed Li T, Cunningham JL, Gilliam WP, Loukianova L, Donegan DM, Bancos I. Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids. J Clin Endocrinol Metab. 2020 Oct 1; 105 (10) View PubMed Graffeo CS, Donegan D, Erickson D, Brown PD, Perry A, Link MJ, Young WF, Pollock BE. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study. Neurosurgery. 2020 Sep 1; 87 (3):538-546 View PubMed Li T, Donegan D, Michael Hooten W, Bancos I. CLINICAL PRESENTATION AND OUTCOMES OF OPIOID INDUCED ADRENAL INSUFFICIENCY. Endocr Pract. 2020 Jun 23 Epub 2020 June 23 View PubMed Saeed ZI, Bancos I, Donegan D. CURRENT KNOWLEDGE AND PRACTICES OF HEATH CARE PROFESSIONALS ON OPIOID-INDUCED ADRENAL INSUFFICIENCY. Endocr Pract. 2019 Oct; 25 (10):1012-1021 Epub 2019 June 06 View PubMed Sauter JL, Lehrke H, Zhang X, Al Badri OT, Rodriguez-Gutierrez R, Delivanis DA, Singh Ospina N, Donegan D, Hamidi O, Iniguez-Ariza N, Sharma A, Kittah NEN, Tamhane SU, Hurtado Andrade MD, Kotwal A, Jenkins SM, Spears G, Rivera M, Dean DS, Henry MR. Assessment of The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2019 Sep 9; 152 (4):502-511 View PubMed Donegan D. Opioid induced adrenal insufficiency: what is new? Curr Opin Endocrinol Diabetes Obes. 2019 Jun; 26 (3):133-138 View PubMed Hamidi O, Van Gompel J, Gruber L, Kittah NE, Donegan D, Philbrick KA, Koeller KK, Erickson D, Natt N, Nippoldt TB, Young WF Jr, Bancos I. MANAGEMENT AND OUTCOMES OF GIANT PROLACTINOMA: A SERIES OF 71 PATIENTS. Endocr Pract. 2019 Apr; 25 (4):340-352 View PubMed Donegan DM, Algeciras-Schimnich A, Hamidi O, Young WF, Nippoldt T, Bancos I, Erickson D. Corticotropin hormone assay interference: A case series. Clin Biochem. 2019 Jan; 63:143-147 Epub 2018 Nov 10 View PubMed Donegan D, Bancos I. Opioid-Induced Adrenal Insufficiency. Mayo Clin Proc. 2018 Jul; 93 (7):937-944 View PubMed Donegan DM, Iniguez-Ariza N, Sharma A, Nippoldt T, Young W, Van Gompel J, Atkinson J, Meyer F, Pollock B, Natt N, Laack N, Erickson D. NECESSITY OF MULTIMODAL TREATMENT OF ACROMEGALY AND OUTCOMES. Endocr Pract. 2018 Jul; 24 (7):668-676 View PubMed Espinosa De Ycaza AE, Donegan D, Jensen MD. Long-term metabolic risk for the metabolically healthy overweight/obese phenotype. Int J Obes (Lond). 2018 Mar; 42 (3):302-309 Epub 2017 Sept 25 View PubMed Singh Ospina N, Ospina NS, Maraka S, Donegan D, Morris JC. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation. Thyroid. 2017 Oct; 27 (10):1332-1334 Epub 2017 Sept 05 View PubMed Donegan D, Jakubikova I, Vella A. ANTHROPOMETRIC FEATURES ARE NOT PREDICTIVE OF 72-HOUR FAST DURATION IN INSULINOMAS. Endocr Pract. 2017 Aug; 23 (8):923-928 Epub 2017 June 14 View PubMed Jasim S, Alahdab F, Ahmed AT, Tamhane SU, Sharma A, Donegan D, Nippoldt TB, Murad MH. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke. Endocrine. 2017 May; 56 (2):267-278 Epub 2016 Nov 04 View PubMed Singh Ospina N, Donegan D, Rodriguez-Gutierrez R, Al-Hilli Z, Young WF Jr. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process. Am J Med. 2017 May; 130 (5):603-605 Epub 2016 Dec 21 View PubMed Donegan D, Singh Ospina N, Rodriguez-Gutierrez R, Al-Hilli Z, Thompson GB, Clarke BL, Young WF Jr. Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours. Clin Endocrinol (Oxf). 2017 Feb; 86 (2):199-206 Epub 2016 Nov 17 View PubMed Donegan D, Atkinson JL, Jentoft M, Natt N, Nippoldt TB, Erickson B, Meyer F, Erickson D. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP. Endocr Pract. 2017 Jan; 23: (1)37-45. View PubMed Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct; 231 (1):71-80 Epub 2016 Aug 12 View PubMed Donegan D, McIver B, Algeciras-Schimnich A. Clinical consequences of a change in anti-thyroglobulin antibody assays during the follow-up of patients with differentiated thyroid cancer. Endocr Pract. 2014 Oct; 20 (10):1032-6 View PubMed Neff K, Donegan D, MacMahon J, O'Hanlon C, Keane N, Agha A, Thompson C, Smith D. Management of parenteral nutrition associated hyperglycaemia: a comparison of subcutaneous and intravenous insulin regimen. Ir Med J. 2014 May; 107: (5)141-3. View PubMed Donegan DM, Vella A. 69-year-old man with recurrent episodes of confusion and diaphoresis. Mayo Clin Proc. 2013 Apr; 88(4):410-3. View PubMed PST-20574808 主页 出版物